Emergent BioSolutions Inc. (EBS) at a glance
Emergent BioSolutions Inc. (EBS) is a small-cap Healthcare company. It trades at $6.53, with a P/E of 8.6, a -23% profit margin and revenue growth of 66.3%. It does not pay a dividend. Vestovix scores it 59/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.
- Price
- $6.53
- Market cap
- $331.2M
- P/E ratio
- 8.6
- Dividend yield
- None
- Beta
- 2.36
- 52-week range
- $4.36 to $14.06
Value
88
Growth
94
Income
40
Safety
12
Momentum
29
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,152.70-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$269.32+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$265.13-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$370.97-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$148.10-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.53+0.92%
2.16% yield
AMGN65
Amgen Inc.
$406.10-1.05%
2.76% yield